Published in BMJ on September 15, 2001
Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. Br J Dermatol (2006) 0.86
Transplant patients need to be made aware of skin cancer risk. BMJ (2002) 0.75
Skin Cancer in the Crosshairs: Highlights from the Biennial Scientific Retreat of International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Recipients Europe. Transplant Direct (2015) 0.75
Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center. Clin Cosmet Investig Dermatol (2015) 0.75
Malignant and noninvasive skin tumours in renal transplant recipients. Dermatol Res Pract (2014) 0.75
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol (1998) 1.25
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis (2000) 1.24
Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol (1995) 1.13
Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc (2001) 1.00
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Variation in general practitioners' referral rates to consultants. J R Coll Gen Pract (1987) 12.16
INTERNAL STRUCTURE AND NUCLEI IN CELLS OF ESCHERICHIA COLI AS SHOWN BY IMPROVED ELECTRON MICROSCOPIC TECHNIQUES. J Bacteriol (1949) 7.86
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet (2007) 6.29
Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol (1987) 5.96
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A (1997) 4.70
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood (1998) 3.06
HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med (1997) 3.03
Glutathione-S-transferase family of enzymes. Mutat Res (2001) 2.74
Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood (2001) 2.61
Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care (2001) 2.53
A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg (1971) 2.46
Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development (1990) 2.42
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol (1998) 2.37
Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci (1997) 2.33
Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci U S A (1998) 2.32
The Use of Sulphocyanate of Soda in High Blood Pressure. Can Med Assoc J (1928) 2.20
The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology (1994) 2.19
Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur J Immunol (1999) 2.15
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell (1990) 2.10
t(8;21) myelodysplasia, an early presentation of M2 AML. Br J Haematol (1995) 2.08
Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol (2000) 1.96
Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med (1993) 1.92
Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol Reprod (2003) 1.91
Crystal structure of aspartate decarboxylase at 2.2 A resolution provides evidence for an ester in protein self-processing. Nat Struct Biol (1998) 1.89
Telomere directed fragmentation of mammalian chromosomes. Nucleic Acids Res (1993) 1.88
Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve (2001) 1.85
A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg (1968) 1.72
Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood (1995) 1.68
Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet (1995) 1.68
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood (1997) 1.65
The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ (1999) 1.60
Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett (2000) 1.59
Multiple genes encoding the conserved CCAAT-box transcription factor complex are expressed in Arabidopsis. Plant Physiol (1998) 1.59
Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol (2002) 1.54
Management of hemorrhage after percutaneous renal surgery. J Urol (1995) 1.53
Epigenetic control of fetal gene expression. BJOG (2007) 1.51
Ototoxicity induced by once-daily gentamicin. Lancet (1998) 1.48
Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect. Biochem J (1980) 1.46
A Schwann cell mitogen accompanying regeneration of motor neurons. Nature (1997) 1.44
Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet (2001) 1.42
The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma. Br J Cancer (1975) 1.42
Nucleic acid concentrations in normal human plasma. Clin Chem (1972) 1.42
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev (1990) 1.32
A single precursor protein for ferrochelatase-I from Arabidopsis is imported in vitro into both chloroplasts and mitochondria. J Biol Chem (1997) 1.32
Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology (2011) 1.32
Use of paraffin wax embedded bone marrow trephine biopsy specimens as a source of archival DNA. J Clin Pathol (1992) 1.31
The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood (1995) 1.31
The development of glutathione S-transferase and glutathione peroxidase activities in human lung. Biochim Biophys Acta (1986) 1.30
Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology (2000) 1.30
GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis. Gut (1993) 1.30
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (1996) 1.28
Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase. Biochem J (1979) 1.25
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics (1998) 1.25
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis (2000) 1.24
Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins. Biochem J (1981) 1.23
The importance of full participation: lessons from a national case-control study. Br J Cancer (2002) 1.22
Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22
Paraneoplastic myopathy: response to intravenous immunoglobulin. Neuromuscul Disord (2007) 1.22
Regulation of a stylar transmitting tissue-specific gene in wild-type and transgenic tomato and tobacco. Mol Gen Genet (1990) 1.21
The use of immunoadsorbent columns for the isolation of antibodies specific for antigens associated with human bronchogenic carcinoma. Br J Cancer (1974) 1.20
Basal cell carcinoma. J R Soc Med (1998) 1.20
Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA. Tissue Antigens (1998) 1.20
Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet (1994) 1.20
Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation. Allergy (2000) 1.19
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res (2000) 1.18
The sterols of the echinoderm Asterias rubens. Biochem J (1973) 1.18
Germ tube and chlamydospore formation by Candida albicans on a new medium. J Clin Microbiol (1975) 1.17
Escherichia coli L-aspartate-alpha-decarboxylase: preprotein processing and observation of reaction intermediates by electrospray mass spectrometry. Biochem J (1997) 1.17
Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms. Ann Hum Genet (2004) 1.17
Gait analysis in a rat model of osteoarthrosis. Physiol Behav (1997) 1.15
Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J (1999) 1.15
Detection of bacteremia by an automated radiometric method and a tubed broth method. Ann Clin Lab Sci (1975) 1.14
Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A (1996) 1.14
New prospects for human stem-cell therapy in the nervous system. Trends Neurosci (1999) 1.13
Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival. Int J Cancer (2001) 1.13
Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. Blood (1990) 1.12
Use of adjustable sutures: a helpful modification. Ann Ophthalmol (1986) 1.12
Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance. Oncogene (2001) 1.12
Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors. Vox Sang (1995) 1.12
Neural differentiation of mouse embryonic stem cells. Biochem Soc Trans (2003) 1.11
The substrate specificity and stereochemistry, reversibility and inhibition of the 3-oxo steroid delta 4-delta 5-isomerase component of cholesterol oxidase. Biochem J (1977) 1.08
Cutaneous infection with Mycobacterium abscessus. Br J Dermatol (1995) 1.08
Sterol biosynthesis in the starfish Asterias rubens and Henricia sanguinolenta. Biochem J (1971) 1.07
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res (1996) 1.06
Cloning and characterization of Tag 1, a tobacco anther beta-1,3-glucanase expressed during tetrad dissolution. Plant Mol Biol (1994) 1.06
Red tattoo reactions: X-ray microanalysis and patch-test studies. Br J Dermatol (1991) 1.06
Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med (1997) 1.06
Effects of glutathione S-transferase M1, T1 and P1 on lung function in asthmatic families. Clin Exp Allergy (2005) 1.06
Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis (1999) 1.06